Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 5311.

https://doi.org/10.1182/blood-2019-129362

Published: 2019

Journal Articles

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Thierry Fest, Fabienne Desmots-Loyer, Mikael Roussel, MD PhD, Celine Pangault, PhD, Cedric Pastoret, MD, Francisco Llamas-Gutierrez, Eric Guiheneuf, Valérie Camara-clayette, Thierry Lamy, Pr, MD PhD, Karin Tarte, PhD, Vincent Ribrag, MD

Blood (2018) 132 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2018-99-113269

Published: 2018

Journal Articles

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Imane Azzaoui, PhD, Fabrice Uhel, MD, Delphine Rossille, PhD, Céline Pangault, PharmD PhD, Joelle Dulong, Jerome Le Priol, PhD, Thierry Lamy, MDPhD, Roch Houot, MD PhD, Steven Le Gouill, MD PhD, Guillaume Cartron, MD PhD, Pascal Godmer, MD, Krimo Bouabdallah, MD, Noel Milpied, MD PhD, Karin Tarte, PhD, Thierry Fest, MD PhD, Mikael Roussel, MD PhD

Blood (2015) 126 (23): 1478.

https://doi.org/10.1182/blood.V126.23.1478.1478

Published: 2015

Journal Articles

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Karin Tarte, PhD, Pangault Celine, PhD, Patricia Ame-Thomas, PhD, Philippe Ruminy, PhD, Delphine Rossille, Gersende Caron, PhD, Maryse Bahia, John De Vos, MD, PhD, Mikael Roussel, MD, PhD, Celine Monvoisin, Thierry Lamy, MD, PhD, Philippe Gaulard, MD, Herve Tilly, MD, Thierry Fest, MD, PhD

Blood (2009) 114 (22): 757.

https://doi.org/10.1182/blood.V114.22.757.757

Published: 2009

Journal Articles

Aneuploidy in Clinical-Grade Mesenchymal Stem Cells Is Not Linked to Cell Transformation and Not Related to Culture Method

Karin Tarte, PhD, Jean-jacques Lataillade, MD, PhD, Loïc Fouillard, MD, PhD, Julien Gaillard, Martine Becker, MD, Delphine Monnier, PhD, Helene Rouard, PhD, Andrei Tchirkov, MD, PhD, Jean-Paul Vernant, Norbert C Gorin, Patrick Gourmelon, Luc Sensebe, MD, PhD

Blood (2008) 112 (11): 3463.

https://doi.org/10.1182/blood.V112.11.3463.3463

Published: 2008

Journal Articles

Bone Marrow Mesenchymal Stem Cells Are Altered in B-Cell Chronic Lymphocytic Leukemia.

Céline Pebrel-Richard, PhD, Richard Veyrat Masson, MD, PhD, Frédérique Dubois-Galopin, PhD, Jean-Jacques Guérin, Laurent Guillouard, Jacques Chassagne, PhD, Jacques-Olivier Bay, MD, PhD, Olivier Tournilhac, MD, PhD, Karin Tarte, PhD, Marc G Berger, MD, PhD

Blood (2008) 112 (11): 2066.

https://doi.org/10.1182/blood.V112.11.2066.2066

Published: 2008

Journal Articles

Quantitative and Functional Alterations of the Gamma Delta T-Cell Subset within Follicular Lymphoma Microenvironment.

Sophie de Guibert, MD, Jean-Baptiste Thibert, Céline Bonnaventure, Patricia Ame-Thomas, PhD, Céline Pangault, PhD, Thierry Fest, MD, PhD, Thierry Lamy, MD, PhD, Karin Tarte, PhD

Blood (2007) 110 (11): 2601.

https://doi.org/10.1182/blood.V110.11.2601.2601

Published: 2007

Journal Articles

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Karin Tarte, PhD, Céline Pangault, PhD, John de Vos, MD, PhD, Philippe Ruminy, PhD, Fabienne Sauvee, Patrick Tas, MD, Jean-Michel Picquenot, MD, Hervé Tilly, MD, PhD, Thierry Lamy, MD, PhD, Christian Bastard, MD, PhD, Thierry Fest, MD, PhD

Blood (2007) 110 (11): 355.

https://doi.org/10.1182/blood.V110.11.355.355

Published: 2007

Journal Articles

Influence of Inflammatory Factors Produced during Graft-Versus-Host Disease on Immunological Properties of Mesenchymal Stem Cells (MSC).

Karin Tarte, PhD, Delphine Monnier, MD, Olivier Tribut, PhD, Joelle Dulong, Céline Bonnaventure, Patricia Ame-Thomas, PhD, Nadège Bescher, Thierry Fest, MD, PhD, Thierry Lamy, MD, PhD, Gilbert Semana, MD, PhD

Blood (2006) 108 (11): 3241.

https://doi.org/10.1182/blood.V108.11.3241.3241

Published: 2006

Journal Articles

Human Mesenchymal Stem Cells Isolated from Bone Marrow and Lymphoid Organs Support Tumor B-Cell Growth: Implications in Follicular Lymphoma Pathogenesis.

Karin Tarte, PhD, Patricia Ame-Thomas, PhD, Hélène Maby-El Hajjami, Céline Monvoisin, Rachel Jean, Thierry Lamy, MD, PhD, Thierry Fest, MD, PhD

Blood (2006) 108 (11): 2409.

https://doi.org/10.1182/blood.V108.11.2409.2409

Published: 2006

Journal Articles

Human Mesenchymal Stem Cells as Precursors of Functional Fibroblastic Reticular Cells: Implications for the Physiopathology of Secondary Lymphoid Organs.

Karin Tarte, PhD, Patricia Ame-Thomas, PhD, Hélène Maby, Sylvie Caulet-Maugendre, MD, PhD, Rachel Jean, Céline Monvoisin, Thierry Lamy, MD, PhD, Thierry Fest, MD, PhD

Blood (2005) 106 (11): 2310.

https://doi.org/10.1182/blood.V106.11.2310.2310

Published: 2005

Journal Articles

IFN-γ, Unlike TNF-α, LPS, or CD40 Signal, Is Required and Sufficient To Induce Indoleamine 2,3-Dioxygenase Activity in Mesenchymal Stem Cells.

Karin Tarte, PhD, Delphine Monnier, MD, Patricia Ame-Thomas, PhD, Joelle Dulong, Céline Bonnaventure, Franck Verite, Thierry Lamy, MD, PhD

Blood (2005) 106 (11): 2311.

https://doi.org/10.1182/blood.V106.11.2311.2311

Published: 2005

NARROW

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12

Follicular Lymphoma Cell Niche: Identification of a Preeminent IL-4-Dependent T FH - B Cell Axis.

Aneuploidy in Clinical-Grade Mesenchymal Stem Cells Is Not Linked to Cell Transformation and Not Related to Culture Method

Bone Marrow Mesenchymal Stem Cells Are Altered in B-Cell Chronic Lymphocytic Leukemia.

Quantitative and Functional Alterations of the Gamma Delta T-Cell Subset within Follicular Lymphoma Microenvironment.

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

Influence of Inflammatory Factors Produced during Graft-Versus-Host Disease on Immunological Properties of Mesenchymal Stem Cells (MSC).

Human Mesenchymal Stem Cells Isolated from Bone Marrow and Lymphoid Organs Support Tumor B-Cell Growth: Implications in Follicular Lymphoma Pathogenesis.

Human Mesenchymal Stem Cells as Precursors of Functional Fibroblastic Reticular Cells: Implications for the Physiopathology of Secondary Lymphoid Organs.

IFN-γ, Unlike TNF-α, LPS, or CD40 Signal, Is Required and Sufficient To Induce Indoleamine 2,3-Dioxygenase Activity in Mesenchymal Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only